Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Lapatinib × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasms 13 Neoplasm Metastasis 6 Breast Neoplasms, Male 6 Brain Neoplasms 6 Head and Neck Neoplasms 5 Ovarian Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteitis Deformans 2 Neuroma, Acoustic 2 Neurofibromatosis 2 2 Inflammatory Breast Neoplasms 2 Esophageal Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Intraductal, Noninfiltrating 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡